-

Allscripts TouchWorks® EHR 20.0 now generally available

New version supports interoperability standards and runs on Chrome

CHICAGO--(BUSINESS WIRE)--Allscripts (NASDAQ: MDRX) has announced Allscripts Touchworks® EHR 20.0, the company’s powerful, scalable and flexible platform designed by clinical and industry experts for large ambulatory practices, is now generally available.

With this new version, TouchWorks EHR runs on Chrome, without the need to install any additional software. TouchWorks 20.0 expands upon Allscripts existing open architecture to support interoperability standards SMART on FHIR and CDS Hooks. This provides clinicians another way to securely embed relevant applications into their core EHR and inject clinical decision support at the point of care.

Developed through a user-centered design process and with modern web conventions, TouchWorks 20.0 features an intuitive design that will require little user training, whether an organization is upgrading from an older version of TouchWorks or is new to the solution. For example, formative user testing shows a 47% increase in SUS (System Usability Scale) scores for the solution’s Charge module.

TouchWorks EHR is a leading EHR platform for large, multi-specialty practices, management services organization (MSO) platforms, and academic and independent delivery networks (IDNs). With its open architecture and configurability, TouchWorks EHR can scale easily and integrate with existing solutions. TouchWorks EHR provides the right solution for ambulatory practices, including teaching and research-oriented practices, to provide improved patient care and to better facilitate population health initiatives.

“The added functionality and expansive benefits of this milestone version of TouchWorks EHR speaks to our commitment to support our valued clients while inviting new organizations to join the Allscripts family," said Vice President of TouchWorks, Amy Elkins. "With these enhancements, we’re ensuring that the clinicians we serve are equipped with forward-looking innovation to address their patients’ needs today and tomorrow.”

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Contacts

Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

Allscripts

NASDAQ:MDRX

Release Versions
Hashtags

Contacts

Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

More News From Allscripts

Veradigm Provides Business and Strategy Update

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, is providing estimated financial performance for the fiscal year 2025 and key areas of strategic focus for 2026. “On my first investor call in October, I committed to advancing three strategic objectives in my first 100 days: reset our business strategy, recover our market leadership with independent physician practices and reignite profitable growth,” said...

Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution

CHICAGO--(BUSINESS WIRE)--Veradigm (OTCMKTS:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey capability that brings the patient voice directly into real‑world evidence generation. The new solution gives life sciences organizations timely, privacy‑preserving insights directly from patients, adding essential context to clinical and observational research. Built on Veradigm’s FollowMyHealth pat...

Veradigm to Release Business Update February 17th and Host Investor Call February 18th

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on February 17, 2026. Veradigm management plans to host an investor conference call and webcast to discuss the Company’s update at 8:00 a.m. Eastern Time on February 18, 2026. Update Call Details Veradigm plans to issue a press release after the c...
Back to Newsroom